Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06738069

Chronic Kidney Disease in Pregnant Females

Screening of Chronic Kidney Disease among pregnant women for early detection

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

CKD

Age range

18 year–50 year

Sex eligibility

Female

Study type

Observational

About this study

Normal pregnancy associated with plasma volume expansion and hormonal changes lead to an increase in GFR of 40% to 65% in first and second trimester , with decrease in GFR of approximately 15% to 20% in the third trimester . Chronic Kidney Disease (CKD) is defined as abnormalities of kidney structure or function, present for a minimum of 3 months, with significant health implications .CKD classification is based on Cause, GFR category (G1-G5), and Albuminuria category (A1-A3), abbreviated as CGA . CKD during pregnancy is a major health concern ,affecting up to 3% of women of reproductive age in high-income countries, but estimated prevalence may be as much as 50% higher in low and middle-income countries (LMICs). Pregnant women with CKD at high risk of adverse maternal and fetal outcome , including hypertension development or worsening ,Preeclampsia, eclampsia , Anemia , platelets abnormalities , worsening kidney function ,need for cesarean section ,Pregnancy loss ,stillbirth ,Preterm labor ,Intrauterine growth restriction . CKD if detected and treated early in its course, ESRD is often preventable, especially for high risk individuals. CKD is often unrecognizable and asymptomatic until it is in its later stages, when the chances of preventing kidney failure are limited. Therefore, in order to administer targeted therapeutic interventions . early identification and stratification of those at highest risk of CKD are urgently needed. Screening programs using state of the art point-of-care testing equipment with blood and urine samples can test for CKD both quickly and accurately

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • -all pregnant women at antenatal care who came to Outpatient clinic at the Women's Health Hospital and Nephrology Outpatient Clinic at Assiut University Hospitals
  • At age of 18 yrs old or above . -Who accept to participate with this study

Exclusion criteria

  • Pregnant women who are known CKD.
  • Pregnant women refuse to participate with this study .
  • Pregnant women with Acute Kidney Injury .

Treatment and study plan

Participants are not assigned an intervention as a part of the study

Other

Participants are not assigned an intervention as a part of the study

Primary outcomes

  1. Percentage of CKD among pregnant women attending antenatal care who came to outpatient clinic at the Women's Health Hospital and Nephrology Outpatient Clinic at Assiut University Hospitals

    Time frame: Through study completion, an average of 3 years

Secondary outcomes

  1. Causes of CKD among pregnant women attending antenatal care who came to Outpatient clinic at the Women's Health Hospital and Nephrology Outpatient Clinic at assuit University Hospitals

    Time frame: Through study completion, an average of 3 years

Study contacts

Contact information is provided by the study sponsor or research team.

Rehab Makram Ibrahim, Doctor

CONTACT

[email protected]

+201014828702

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Frequency of Chronic Kidney Disease Among Pregnant Women at Assuit University Hospitals

Important dates

Study start
2024
Primary completion
2028
Study completion
2029
First posted
Dec 17, 2024
Registry last updated
Dec 17, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.